4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-008128
EVP, Chief Dev. Officer sold 1,991 shares at $9.86 ($19,635)
From the SEC's structured data for this filing
Trades in this filing
Frenkel Ran · EVP, Chief Dev. Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-07 | Sale : show line 1 in the form | −1,991 | $9.86 | $19,635 | 104,632 | D |
| Open-market sales · 1,991 sh · avg $9.86 · $19,635 | ||||||
Loading xslF345X03/doc4.xml…